CDH1 and breast carcinoma: EMT phenotype was further explored by protein detection of E-cadherin and vimentin, two critical markers of the epithelial and mesenchymal status in cancer cells and similarly reversed EMT signature was observed in two different mouse breast cancer models following clodronate treatment (Figures 2G and S5).